Citalopram Hydrobromide



Combined with:

Yaz

Indications and Reactions:

Role Indications Reactions
Primary
Depression 42.8%
Product Used For Unknown Indication 22.2%
Drug Use For Unknown Indication 8.8%
Anxiety 5.9%
Schizophrenia 2.5%
Hypertension 2.1%
Major Depression 2.0%
Depressed Mood 1.9%
Psychotic Disorder 1.6%
Bipolar Disorder 1.3%
Obsessive-compulsive Disorder 1.3%
Intentional Overdose 1.3%
Pain 1.2%
Anxiety Disorder 0.9%
Atrial Fibrillation 0.9%
Parkinson's Disease 0.9%
Migraine 0.7%
Sleep Disorder 0.7%
Drug Exposure During Pregnancy 0.6%
Schizoaffective Disorder 0.6%
Vomiting 9.1%
Completed Suicide 9.0%
Serotonin Syndrome 7.4%
Tremor 7.2%
Maternal Drugs Affecting Foetus 6.5%
Overdose 5.8%
Suicidal Ideation 5.6%
Respiratory Arrest 5.5%
Hyponatraemia 5.3%
Suicide Attempt 5.3%
Drug Interaction 4.6%
Tachycardia 4.1%
White Blood Cell Count Increased 3.6%
Somnolence 3.5%
Toxicity To Various Agents 3.4%
Weight Increased 3.1%
Multiple Drug Overdose 3.0%
Syncope 2.8%
Drug Toxicity 2.7%
Electrocardiogram Qt Prolonged 2.5%
Secondary
Product Used For Unknown Indication 31.0%
Drug Use For Unknown Indication 24.5%
Depression 19.2%
Anxiety 4.3%
Hypertension 3.6%
Psychotic Disorder 2.2%
Major Depression 2.1%
Schizophrenia 1.8%
Pain 1.6%
Obsessive-compulsive Disorder 1.2%
Bacteraemia 1.0%
Bipolar Disorder 1.0%
Epilepsy 1.0%
Parkinson's Disease 0.9%
Dementia Alzheimer's Type 0.9%
Ill-defined Disorder 0.8%
Depressed Mood 0.8%
Hypothyroidism 0.8%
Sleep Disorder 0.7%
Type 2 Diabetes Mellitus 0.7%
Completed Suicide 16.5%
Respiratory Arrest 10.0%
Death 7.5%
Suicide Attempt 7.5%
Overdose 6.7%
Vomiting 6.5%
Toxicity To Various Agents 6.0%
Serotonin Syndrome 4.8%
Drug Toxicity 4.1%
Drug Interaction 3.6%
Poisoning 3.3%
Hyponatraemia 3.2%
Cardio-respiratory Arrest 3.1%
Tremor 3.1%
White Blood Cell Count Increased 2.6%
Drug Abuse 2.5%
Weight Decreased 2.3%
Somnolence 2.2%
Withdrawal Syndrome 2.2%
Multiple Drug Overdose 2.1%
Concomitant
Product Used For Unknown Indication 27.0%
Drug Use For Unknown Indication 20.3%
Depression 11.5%
Hypertension 6.0%
Pain 4.9%
Anxiety 3.7%
Rheumatoid Arthritis 3.6%
Schizophrenia 2.7%
Multiple Sclerosis 2.1%
Hepatitis C 2.1%
Prophylaxis 1.9%
Insomnia 1.9%
Hiv Infection 1.7%
Osteoporosis 1.7%
Gastrooesophageal Reflux Disease 1.6%
Diabetes Mellitus 1.6%
Bipolar Disorder 1.5%
Asthma 1.5%
Multiple Myeloma 1.3%
Blood Cholesterol Increased 1.3%
Vomiting 14.2%
Weight Decreased 8.7%
Weight Increased 8.1%
Tremor 5.3%
Withdrawal Syndrome 4.6%
Nausea 4.5%
Death 4.4%
Pneumonia 4.4%
White Blood Cell Count Decreased 4.2%
Thrombocytopenia 4.2%
Pulmonary Embolism 4.1%
Urinary Tract Infection 4.1%
Vision Blurred 3.9%
Pain 3.8%
Suicidal Ideation 3.8%
Type 2 Diabetes Mellitus 3.6%
Depression 3.6%
Renal Failure Acute 3.6%
Somnolence 3.5%
Syncope 3.5%
Interacting
Product Used For Unknown Indication 21.1%
Depression 20.2%
Drug Use For Unknown Indication 13.2%
Hypertension 7.9%
Mental Disorder 5.2%
Schizophrenia 3.6%
Deep Vein Thrombosis 3.1%
Anxiety 2.9%
Atrial Fibrillation 2.6%
Dyslipidaemia 2.3%
Somatoform Disorder 2.3%
Bone Pain 2.2%
Constipation 2.2%
Gastritis 1.9%
Pain 1.7%
Suicide Attempt 1.7%
Borderline Personality Disorder 1.5%
Epilepsy 1.5%
Psychotic Disorder Due To A General Medical Condition 1.5%
Hepatitis C 1.3%
Drug Interaction 31.3%
Serotonin Syndrome 18.4%
Restlessness 5.4%
Hyponatraemia 3.4%
Hypotension 3.4%
Myopathy 3.4%
Thyroxine Free Increased 3.4%
White Blood Cell Count Increased 3.4%
Duodenal Ulcer Haemorrhage 2.7%
Encephalitis 2.7%
International Normalised Ratio Increased 2.7%
Suicidal Ideation 2.7%
Suicide Attempt 2.7%
Depression 2.0%
Dizziness 2.0%
Drug Level Above Therapeutic 2.0%
Paranoia 2.0%
Speech Disorder 2.0%
Torsade De Pointes 2.0%
Vomiting 2.0%